4.1 Article

Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Microbiology

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu et al.

Summary: This review summarizes the research progress on SARS-CoV-2 and COVID-19, including virology characteristics, pathogenesis, and recent advances in treatment methods. Furthermore, it discusses in detail the potential wildlife hosts and zoonotic origin of this emerging virus.

NATURE REVIEWS MICROBIOLOGY (2021)

Review Microbiology

Review of the use of nasal and oral antiseptics during a global pandemic

Christopher Stathis et al.

Summary: The review suggests that commonly used antiseptics should be studied in clinical trials to mitigate the progression and transmission of SARS-CoV-2. Current research shows these antiseptics can significantly reduce viral load in vitro and may be used for prevention and early treatment.

FUTURE MICROBIOLOGY (2021)

Article Physiology

Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures

Desiree Schuetz et al.

Summary: The study found that carrageenan in certain nasal and mouth sprays can effectively inhibit SARS-CoV-2 infection, reducing the risk of viral spread.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)

Article Multidisciplinary Sciences

Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro

Martina Morokutti-Kurz et al.

Summary: Iota-carrageenan has shown to inhibit cell entry of SARS-CoV-2 virus and replication, with potential antiviral effects demonstrated in vitro. Clinical studies have also indicated that iota-carrageenan can reduce severity and duration of symptoms caused by various respiratory viruses, suggesting it may be an effective prophylaxis or treatment for SARS-CoV-2 infections.

PLOS ONE (2021)

Letter Medicine, General & Internal

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Lirong Zou et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Immunology

COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

Serena Colafrancesco et al.

AUTOIMMUNITY REVIEWS (2020)

Letter Medicine, Research & Experimental

Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19

Oisin Kavanagh et al.

MEDICAL HYPOTHESES (2020)

Editorial Material Medicine, General & Internal

Therapy for Early COVID-19 A Critical Need

Peter S. Kim et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Cell Biology

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia

Andres Pizzorno et al.

CELL REPORTS MEDICINE (2020)

Article Biochemical Research Methods

A lung/liver-on-a-chip platform for acute and chronic toxicity studies

David Bovard et al.

LAB ON A CHIP (2018)

Article Medicine, General & Internal

Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat

Martina Morokutti-Kurz et al.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2017)

Article Medicine, Research & Experimental

3-D nasal cultures: Systems toxicological assessment of a candidate modified-risk tobacco product_suppl

Anita Iskandar

ALTEX-Alternatives to Animal Experimentation (2016)

Review Biochemical Research Methods

TEER Measurement Techniques for In Vitro Barrier Model Systems

Balaji Srinivasan et al.

Article Respiratory System

Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials

Martin Koenighofer et al.

MULTIDISCIPLINARY RESPIRATORY MEDICINE (2014)

Article Multidisciplinary Sciences

Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection

Andreas Leibbrandt et al.

PLOS ONE (2010)

Article Virology

Iota-Carrageenan is a potent inhibitor of rhinovirus infection

Andreas Grassauer et al.

VIROLOGY JOURNAL (2008)